{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:39:16Z","timestamp":1761061156974,"version":"3.37.3"},"reference-count":27,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Virology"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:label\/><jats:p>Some have hypothesized that the use of angiotensin\u2010converting enzyme inhibitors (ACEI) and angiotensin\u2010receptor blockers (ARB) may modify susceptibility to coronavirus disease\u20102019 (COVID\u201019) in humans. Thus, we conducted two meta\u2010analyses to investigate the effect of ACEI and ARB on mortality and susceptibility to COVID\u201019. Pubmed and EMBASE were searched through June 2020 to identify clinical trials that investigated the testing positive and in\u2010hospital mortality rates for COVID\u201019 for those who were treated with ACEI and\/or ARB and for those who were not treated with ACEI or ARB. The first analysis investigated the testing positive rate of COVID\u201019. The second analysis investigated the in\u2010hospital mortality rate for patients with COVID\u201019. Three eligible studies for the first analysis and 14 eligible studies for the second analysis were identified. The first analysis demonstrated that the use of ACEI or ARB did not affect the testing positive rates (odds ratio [OR] [confidence interval [CI]]\u2009=\u20090.96 [0.88\u20131.04]; <jats:italic>p<\/jats:italic>\u2009=\u2009.69, OR [CI]\u2009=\u20090.99 [0.91\u20131.08]; <jats:italic>p<\/jats:italic>\u2009=\u20090.35, respectively). The second analysis showed that the use of ACEI and\/or ARB did not affect in\u2010hospital mortality (risk ratio [RR] 95% [CI]]\u2009=\u20090.88 [0.64\u20131.20], <jats:italic>p<\/jats:italic>\u2009=\u20090.42). The subgroup analysis by limiting studies of patients with hypertension showed ACEI and\/or ARB use was associated with a significant reduction of in\u2010hospital mortality compared with no ACEI or ARB use (RR [CI]\u2009=\u20090.66 [0.49\u20100.89], <jats:italic>p<\/jats:italic>\u2009=\u20090.004). Our analysis demonstrated that ACEI and\/or ARB use was associated neither with testing positive rates of COVID\u201019 nor with mortality of COVID\u201019 patients.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jmv.26588","type":"journal-article","created":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T14:25:52Z","timestamp":1602339952000},"page":"2084-2089","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Association of renin\u2010angiotensin\u2010aldosterone system inhibitors with mortality and testing positive of COVID\u201019: Meta\u2010analysis"],"prefix":"10.1002","volume":"93","author":[{"given":"Yujiro","family":"Yokoyama","sequence":"first","affiliation":[{"name":"Department of Surgery St. Luke's University Health Network  Bethlehem Pennsylvania USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1786-0176","authenticated-orcid":false,"given":"Tadao","family":"Aikawa","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Center Icahn School of Medicine at Mount Sinai  New York City New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5594-8072","authenticated-orcid":false,"given":"Hisato","family":"Takagi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery Shizuoka Medical Center  Shizuoka Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandros","family":"Briasoulis","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Section of Heart Failure and Transplantation University of Iowa  Iowa City Iowa USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2487-8366","authenticated-orcid":false,"given":"Toshiki","family":"Kuno","sequence":"additional","affiliation":[{"name":"Department of Medicine, Icahn School of Medicine at Mount Sinai Mount Sinai Beth Israel  New York City New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,10,30]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature02145"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.510461"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1267"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104927"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.05.052"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvaa064"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007621"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.10.059"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000100"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2008975"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1855"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2008975"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvaa056"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.15312"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa433"},{"issue":"7","key":"e_1_2_8_17_1","first-page":"1","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID\u201019)","volume":"27","author":"Guo T","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"20","key":"e_1_2_8_18_1","article-title":"COVID\u201019 patients with hypertension have more severity condition, and ACEI\/ARB treatment have no influence on the clinical severity and outcome","volume":"0163","author":"Hu J","year":"2020","journal-title":"J Infect"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa624"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1624"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2020.1746200"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.6775"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa492"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.15143"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.317134"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.15622"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsr2005760"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007621"}],"container-title":["Journal of Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jmv.26588","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jmv.26588","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jmv.26588","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T10:06:20Z","timestamp":1721124380000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jmv.26588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,30]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1002\/jmv.26588"],"URL":"https:\/\/doi.org\/10.1002\/jmv.26588","archive":["Portico"],"relation":{},"ISSN":["0146-6615","1096-9071"],"issn-type":[{"type":"print","value":"0146-6615"},{"type":"electronic","value":"1096-9071"}],"subject":[],"published":{"date-parts":[[2020,10,30]]},"assertion":[{"value":"2020-08-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}